Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 28, Issue 8, 2006, Pages 578-582

  Xu, Jian ming ^a   Li, Yue min ^a   Wang, Yan ^a   Zhao, Chuan hua ^a   Yuan, Shou jun ^a   Yang, Wu wei ^a   Li, Zhi qiang ^a   Han, Y ^a   Azzariti, Amalia ^a   Paradiso, Angelo ^a  

^a Beijing 307 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DNA TOPOISOMERASE; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; IRINOTECAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE B; QUINAZOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN HT29; CELL SURVIVAL; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; HUMAN; IC 50; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DNA TOPOISOMERASES, TYPE I; DRUG SYNERGISM; HT29 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 36749043825     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)